Stock Insights on NuVasive, Inc. (NASDAQ:NUVA)

By Justin Cohen Article: Several analysts have recently weighed on NuVasive, Inc. (NASDAQ:NUVA), issuing notes to investors. William Plovanic of Canaccord Genuity reiterated their Buy rating on the stock yesterday with a $54.00 price target, or 26.26% upside to the

© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1